logo
Plus   Neg
Share
Email

ANI Pharma Guides FY20 Below Estimates - Quick Facts

While reporting financial results for the fourth quarter on Thursday, ANI Pharmaceuticals Inc. (ANIP) initiated its adjusted earnings and revenue guidance for the full-year 2020, below analysts' estimates.

For fiscal 2020, the company now projects adjusted earnings in a range of $ $4.46 to $4.86 per share on revenues between $213 million and $223 million.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $5.47 per share on revenues of $229.15 million for the year. Analysts' estimates typically exclude special items.

The company also said it successfully completed its fourth commercial scale batch of both Corticotropin API and the Cortrophin Gel drug product and remains on track to submit its supplemental NDA filing in March 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Tesla said it will produce ventilators at its Gigafactory in Buffalo, New York to support the city's hospitals amid the coronavirus pandemic. New York is the worst affected state in the U.S. Last Saturday, Musk tweeted that he "had a long engineering discussion with Medtronic about state-of-the-art ventilators. Luxury fashion house Ralph Lauren will donate $10 million to help fight the coronavirus pandemic and manufacture face masks as well as medical gowns in the U.S. The company's charity arm, the Ralph Lauren Corporate Foundation, said in a statement that it is committing $10 million towards the global response to the COVID-19 pandemic. General Motors Co. is delaying work on new vehicle models and is cutting pay for its executives as part of efforts to conserve cash amid the coronavirus or Covid-19 pandemic. The automotive giant also extended the shutdown of North American plants indefinitely. Multiple reports cited an internal memo that salaried workforce will have 20 percent of pay deferred starting April 1.
Follow RTT
>